AspireBio has provided regulatory support for our Phase 1 and Phase 2 clinical trials of an inhaled COVID Vaccine. Our trials have benefited immensely from their expert knowledge in regulatory compliance and vaccine biotechnology. We have enjoyed a positive working relationship with AspireBio, whose staff demonstrate efficiency and professionalism in their work.